Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...

Supermodel Elle Macpherson has continued to promote her controversial memoir in New York months after claiming she cured her ...

Merck's Keytruda sales rose 17.2% YoY to $7.43 billion. Find out why MRK stock's strong fundamentals and high dividend yield ...

A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...

A small trial of an experimental vaccine has shown promising results for patients with the most aggressive type of breast ...

RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more ...

Today's health news includes how RFK Jr. could strip legal protections from vaccine makers and why more young people are getting cancer.

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

An experimental vaccine showed promise in treating aggressive breast cancer, while a new gene therapy method advances ...

After surgery, the team analyzed and compared the tumor tissue with the healthy tissue of the same patient to find unique ...